Tonix Pharmaceuticals (NASDAQ:TNXP) reported favorable results for the tests on its lead drug candidate TNX 102 SL. The pharma company had conducted fed-fasting and dose proportionality tests of the drug candidate in healthy volunteers. The data will be used to support a New Drug Application for treating post-traumatic stress disorderRead More →

Investment Thesis Adaptive Biotechnologies Corporation (ADPT) has declined ~36% since its IPO in late July last year, at a time Nasdaq Biotechnology Index has risen ~9%. Despite its foray into therapeutics and early diagnostics, the company’s tissue-based cancer detection is still confined to a few less common cancers. Meanwhile, itsRead More →

My title today derives from a quotation attributed to rear admiral David Farragut during the 1864 Battle of Mobile Bay. The actual sequence went more like this: Damn those torpedoes! “From his high perch, where he was lashed to the rigging of his flagship, USS Hartford, Farragut could see theRead More →

Asian markets gained in early trading Friday after a senior Chinese official said negotiations for a phase-one trade deal with the U.S. are progressing. Gao Feng, China’s minister of commerce, said Thursday that negotiators are in “close communication” and offered reassurances despite recent tensions. However, he also emphasized that ChinaRead More →

Yields on U.S. government debt rose Wednesday as Treasury prices gave back some of the previous session’s large gains following a news report that said the U.S. and China remained on track to complete a phase-one trade deal before a Dec. 15 deadline despite President Trump’s comments about a delayRead More →